Metabolic Pathways of Leishmania Parasite: Source of Pertinent Drug Targets and Potent Drug Candidates

Surbhi Jain, Utkarsha Sahu, Awanish Kumar, Prashant Khare

Open source

DOI
10.3390/pharmaceutics14081590
Published
2022-07-30
Container
Pharmaceutics
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/pharmaceutics14081590,
  title = {Metabolic Pathways of Leishmania Parasite: Source of Pertinent Drug Targets and Potent Drug Candidates},
  author = {Surbhi Jain and Utkarsha Sahu and Awanish Kumar and Prashant Khare},
  year = {2022},
  journal = {Pharmaceutics},
  doi = {10.3390/pharmaceutics14081590},
  url = {https://doi.org/10.3390/pharmaceutics14081590}
}

RIS

TY  - JOUR
TI  - Metabolic Pathways of Leishmania Parasite: Source of Pertinent Drug Targets and Potent Drug Candidates
AU  - Surbhi Jain
AU  - Utkarsha Sahu
AU  - Awanish Kumar
AU  - Prashant Khare
PY  - 2022
JO  - Pharmaceutics
DO  - 10.3390/pharmaceutics14081590
UR  - https://doi.org/10.3390/pharmaceutics14081590
ER  - 

APA

Jain, S., Sahu, U., Kumar, A., & Khare, P. (2022). Metabolic Pathways of Leishmania Parasite: Source of Pertinent Drug Targets and Potent Drug Candidates. Pharmaceutics. https://doi.org/10.3390/pharmaceutics14081590

Source records